Company intelligence / Profile preview

Calico Life Sciences

South San Francisco, California, United Statescalicolabs.com ↗
Ownership
Private
Employees
~365
Development stage
Phase 1
01

Overview

Calico Life Sciences focuses on understanding the fundamental biology that controls human aging and translating these discoveries into interventions targeting age-related diseases. The company has a growing pipeline spanning preclinical to early clinical stages, with notable progress in rare neurodegenerative disease therapeutics such as Fosigotifator for Vanishing White Matter Disease. Its approach combines advanced computation, interdisciplinary research, and extensive collaborations with industry leaders like AbbVie. While the company has not yet produced late-stage or commercialized therapies as of early/mid‑2025, it remains a leading innovator in longevity science.[1][3]

Therapeutic areas
OtherOncologyNeurology
Modalities
Small molecules[3]Potentially biologics (inferred from broad R&D focus)[2]Advanced computing and systems biology approaches[1][2]
Industry
Biotech
02

Drug pipeline

5 assets

fosigotifator

3

4 more assets in the full pipeline.

03

Partnerships

AbbVie — major R&D collaboration focused on age-related disease therapeutics ($billions committed over a decade) [3]Denali Therapeutics — ALS drug development partnership [3]Terray Therapeutics — small-molecule discovery collaboration [3]

Beyond the preview

Go deeper on Calico Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calico Life Sciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call